RARE Act

The RARE Act amends the Federal Food, Drug, and Cosmetic Act to limit the 7-year market exclusivity for orphan drugs (designed for rare diseases or conditions). Instead of exclusivity covering the entire rare disease or condition, it now applies only to the specific "approved use or indication." This change prevents a drug from blocking competitors for other uses within the same rare disease....